|Videos|July 24, 2023

Safety Profile of S1P Receptor Modulators for Multiple Sclerosis

Krzysztof Selmaj, MD, PhD, discusses the side effects of sphinogine-1-phospate (S1P) receptor modulators, highlighting particular adverse events clinicians should be aware of when treating multiple sclerosis (MS).


Latest CME